Valuation : Almirall, S.A.

Market Cap 2.29B 2.65B 2.15B 1.96B 3.68B 252B 3.7B 25.43B 9.9B 128B 9.95B 9.74B 424B P/E 2026 *
27.1x
P/E 2027 * 19.4x
Enterprise Value 2.19B 2.54B 2.06B 1.88B 3.54B 241B 3.55B 24.39B 9.49B 123B 9.55B 9.34B 407B EV / Sales 2026 *
1.79x
EV / Sales 2027 * 1.52x
Free-Float
35.93%
Yield 2026 *
1.93%
Yield 2027 * 2%
1 day+1.74%
1 week+1.16%
Current month+1.74%
1 month-5.41%
3 months-5.58%
6 months-18.48%
Current year-18.22%
1 week 10.22
Extreme 10.22
10.54
1 month 10.22
Extreme 10.22
11.14
Current year 10.22
Extreme 10.22
13.98
1 year 10.22
Extreme 10.22
13.98
3 years 7.85
Extreme 7.85
13.98
5 years 7.16
Extreme 7.16
14.83
10 years 7.16
Extreme 7.16
18.5
Manager TitleAgeSince
Chief Executive Officer - 02/11/2022
Director of Finance/CFO 53 31/08/2025
Chief Tech/Sci/R&D Officer - 07/07/2021
Director TitleAgeSince
Director/Board Member - 01/01/2014
Director/Board Member - 01/01/2016
Chairman - 06/05/2022
Date Insider Type Main position Quantity % Market Cap. Importance
6/23/23 A Buy

Executive/Senior Manager

3,000 0.0017%
6/22/23 A Buy 4,340 0.0024%
6/22/23 A Buy

Executive/Senior Manager

5,000 0.0028%
Change 5-day change 1-year change 3-year change Capi.($)
+1.74%+1.16%-6.08%+11.58% 2.61B
+0.28%-5.97%+58.34%+108.22% 1,031B
+2.01%-0.71%+53.07%+68.99% 641B
+1.39%-2.18%+23.57%+75.43% 453B
-1.50%-7.04%+33.55%+33.94% 349B
+6.25%+2.04%+28.97%+46.57% 290B
-0.07%-4.12%+0.95%+11.79% 252B
+1.92%-0.93%+52.28%+70.67% 232B
+0.51%-4.52%-19.50%-54.83% 201B
+2.45%+0.77%+32.71%+95.59% 181B
Average +1.63%-2.50%+25.79%+46.80% 363.24B
Weighted average by Cap. +1.60%-3.39%+38.35%+66.36%

Financials

2026 *2027 *
Net sales 1.23B 1.42B 1.15B 1.05B 1.98B 135B 1.99B 13.65B 5.31B 68.72B 5.34B 5.23B 228B 1.35B 1.57B 1.27B 1.16B 2.18B 149B 2.19B 15.03B 5.85B 75.66B 5.88B 5.76B 251B
Net income 82.4M 95.52M 77.51M 70.61M 133M 9.07B 134M 916M 357M 4.61B 359M 351M 15.29B 115M 134M 109M 98.88M 186M 12.7B 187M 1.28B 499M 6.46B 502M 491M 21.41B
Net Debt -93.03M -108M -87.51M -79.73M -150M -10.24B -151M -1.03B -403M -5.21B -405M -396M -17.26B -228M -264M -214M -195M -367M -25.07B -369M -2.53B -986M -12.75B -992M -970M -42.29B
Logo Almirall, S.A.
Almirall SA is a Spain-based company principally engaged in the pharmaceuticals manufacture. The Company focuses on development and marketing of drugs applied in various therapeutic areas, such as nervous system, gastrointestinal, dermatological, respiratory system, antiinfectives, as well as antineoplastic and immunomodulating agents. The Company's activities are divided into four business segments: Own network, which focuses on the commercialization of pharmaceuticals through own brand names; Licenses, which sells product rights to third parties; Research and development (R&D), which is responsible for the creation of drug candidates, as well as Dermatology, which includes sale of dermatological medicines in the United States. The Company operates through numerous subsidiaries in Europe, the Americas, Africa, Asia and Australia.
Employees
2,097
Date Price Change Volume
01/09/26 €10.50 +1.74% 133,134
31/08/26 €10.32 0.00% 261,137
28/08/26 €10.32 -0.77% 75,044
27/08/26 €10.40 -0.95% 131,088
26/08/26 €10.50 +1.16% 91,481
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
10.50EUR
Average target price
14.30EUR
Spread / Average Target
+36.19%

Quarterly revenue - Rate of surprise